Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antidepressants in pregnancy.

Adrienne Einarson1, Gideon Koren

  • 1Hospital for Sick Children, Toronto, Ont.

Canadian Family Physician Medecin De Famille Canadien
|March 6, 2004
PubMed
Summary

For pregnant women with depression, fluoxetine is the recommended treatment due to the most available safety data. Newer antidepressants like venlafaxine may also be considered, with ongoing research aiding informed decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Mirtazapine an Effective Treatment for Nausea and Vomiting of Pregnancy?: A Case Series.

Journal of clinical psychopharmacology·2017
Same author

Prenatal Antidepressant Use and Risk of Autism Spectrum Disorders in Children.

JAMA pediatrics·2016
Same author

Antidepressant use in pregnancy: knowledge transfer and translation of research findings.

Journal of evaluation in clinical practice·2015
Same author

Developmental risks associated with use of psychoactive drugs during pregnancy are largely unknown. Authors' reply.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2014
Same author

Antidepressant use in pregnancy: an evaluation of adverse outcomes excluding malformation.

The Israel journal of psychiatry and related sciences·2014
Same author

Health literacy and its association with perception of teratogenic risks and health behavior during pregnancy.

Patient education and counseling·2014

Area of Science:

  • Perinatology
  • Pharmacology
  • Psychiatry

Background:

  • Depression during pregnancy requires appropriate treatment.
  • Selective serotonin reuptake inhibitors (SSRIs) are commonly used.
  • Patient cases may involve non-response to traditional SSRIs.

Purpose of the Study:

  • To provide guidance on antidepressant selection for depression during pregnancy.
  • To address the use of venlafaxine in a pregnant patient with prior SSRI non-response.

Main Methods:

  • Review of current evidence on antidepressant safety in pregnancy.
  • Consideration of clinical case data for treatment decisions.

Main Results:

  • Fluoxetine is the recommended first-line agent due to extensive safety evidence.
  • Venlafaxine, a newer antidepressant, is being used effectively in some cases.

Conclusions:

  • Appropriate treatment of depression in pregnancy is crucial.
  • Fluoxetine has the most established safety profile for use during gestation.
  • Further research on newer antidepressants like venlafaxine is valuable for informed clinical decision-making.

Related Experiment Videos